SRC
DGX icon

Stone Run Capital’s Quest Diagnostics DGX Stock Holding History

Stone Run Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,650
Closed -$644K – 62
2020
Q2 		$644K Sell
5,650
-4,350
-44% -$461K 0.32% 42
2020
Q1 		$803K Buy
+10,000
New +$1.04M 0.46% 44

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Stone Run Capital's DGX Position: Q3 2020 in Review

Stone Run Capital sold out of Quest Diagnostics (DGX) in Q3 2020, closing a stake of 5,650 shares — an estimated $644K sold.

Stone Run Capital first reported a position in DGX in Q1 2020 and held it in 2 quarters. The position peaked at $803K in Q1 2020. 757 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • Stone Run Capital reported no remaining Quest Diagnostics position as of Q3 2020 after selling out during the quarter.
  • Stone Run Capital sold 5,650 Quest Diagnostics shares in Q3 2020, an estimated $644K.
  • Stone Run Capital first reported a position in Quest Diagnostics in Q1 2020 and held it in 2 quarters.
  • Stone Run Capital's Quest Diagnostics position peaked at $803K in Q1 2020.
  • 757 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on Stone Run Capital's 13F filing for Q3 2020, filed 13 Nov 2020.